This site is intended for healthcare professionals only

Digest Debate


Pioglitazone and bladder cancer
Gastric surgery and the incidence of longer-term hypoglycaemic events
For safety’s sake: Best practice for assisted monitoring of blood glucose
Raised inflammatory markers and cognitive decline in older people with T2D
Assessing CV risk in people with type 2 diabetes on oral antidiabetes drugs
Does treatment of mild gestational diabetes reduce the risk of adverse outcomes?
Cardiovascular outcomes with pioglitazone compared with rosiglitazone
Could financial incentives be used to slow the diabetes epidemic?
What role for aspirin and antioxidants in the prevention of cardiovascular events?
Does intensive blood glucose control confer long-term risk reduction?
Does intensive blood glucose control improve vascular outcomes in T2DM?
Can insulin glargine achieve target HbA1c as well as insulin lispro?
Can behavioural intervention help at-risk people increase their physical activity?
Simplicity cannot control HbA 1c: Interim results of the 4-T trial
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals


By clicking ‘Subscribe’, you are agreeing that are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.